LPC(Lysophosphatidyl choline) ELISA Kit

What it means: Target is the analyte this ELISA is designed to measure. The target on this page is LPC (Lysophosphatidyl choline).

Most ELISA targets are proteins (often gene products) used as biomarkers for pathway activity, disease models, or treatment response.

Why it matters:

• Correct match: Use the target name/synonym (Lysophosphatidyl choline) to confirm you’re measuring the right biomarker (isoforms and closely related family members can differ).
• Species fit: This kit is listed as General reactivity—choose a kit matched to your organism to avoid reduced binding and inaccurate quantification.
• Interpretation: Baseline abundance varies widely by tissue, treatment, and disease state—plan controls and a dilution series to keep readings within the standard curve.

How to interpret here: The chip value shows the target as LPC (Lysophosphatidyl choline). Use it to align your study design (samples, expected range, and controls) and follow the recommended standard curve and dilution guidance.

What it means: Reactivity indicates the species the antibodies/standards in the kit are validated to detect. This kit is listed as General.

Why it matters:

• When it’s used: “General” is often used for conserved targets or non-species-specific analytes where the same assay can be applied across multiple organisms.
• Still verify: Matrix effects and sequence differences can still impact results—run a small pilot with representative samples before scaling up.
• Controls: Include standards and controls in the same sample matrix whenever possible (serum vs plasma vs lysate can behave differently).

How to interpret here: Treat General as a starting point, not a guarantee—confirm fit with your sample type and organism using a pilot run.

What it means: A Competitive Inhibition ELISA measures target by competition—sample analyte competes with a labeled/plate-bound analyte, so signal is typically inversely related to concentration.

Why it matters:

• Best for small targets: Often used for small molecules, metabolites, or modified analytes that cannot be “sandwiched” by two antibodies.
• Curve direction: Because the readout is inverse, careful standard preparation and consistent timing are critical for accurate quantification.
• Interpretation: Small differences in handling can shift the curve—run standards and controls on every plate.

How to interpret here: The chip value Competitive Inhibition means higher analyte usually produces lower signal—interpret results using the provided standard curve model.

What it means: Sensitivity is the lowest concentration the assay can reliably distinguish from background under the recommended conditions. The listed sensitivity is 92.4 ng/mL.

Why it matters:

• Low-abundance targets: Higher sensitivity (a lower number) helps when expected levels are near the detection limit.
• Plan dilutions: If samples are concentrated, dilute into the assay range; if levels are very low, optimize sample prep to improve recovery.
• Matrix matters: Real samples can reduce effective sensitivity—use matrix-matched standards or include spiking/recovery checks when possible.

How to interpret here: Use 92.4 ng/mL to judge whether the kit can detect your expected baseline levels. If you expect concentrations close to this value, run a pilot with a dilution series to confirm reliable quantification.